<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The risk factors for intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> are unclear but may differ from those for other <z:hpo ids='HP_0001297'>stroke</z:hpo> subtypes </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we investigated whether <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, an emerging risk factor for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, is associated with intracranial atherosclerotic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Using the Adults Treatment Panel III criteria, we evaluated the components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in 439 patients with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> or <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> within each <z:hpo ids='HP_0001297'>stroke</z:hpo> subtype was determined, and the association between intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> was observed more frequently in patients with intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> than in those with other types of <z:hpo ids='HP_0001297'>stroke</z:hpo> (P=0.003) </plain></SENT>
<SENT sid="5" pm="."><plain>In a multiple regression analysis, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, but not conventional risk factors, was independently associated with intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (P=0.016) </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, the serum level of C-reactive protein was correlated negatively with the presence of intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Intracranial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was most prevalent in patients with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and low levels of C-reactive protein (P=0.024) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our results indicate that <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is a strong independent risk factor for intracranial atherosclerotic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, treatment of <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> may be an important prevention strategy for intracranial atherosclerotic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>